key: cord-0822543-z7rm2ud5
authors: Selarka, Lav; Sharma, Arvind K; Rathod, Gaurang; Saini, Dinesh; Patel, Sanket; Sharma, Vijay K
title: Mucormycosis- A Dreaded Complication Of Covid-19
date: 2021-06-14
journal: QJM
DOI: 10.1093/qjmed/hcab166
sha: 0f6d12bafc6e99ff8dc02c05db215ec72b1267b6
doc_id: 822543
cord_uid: z7rm2ud5

Covid-19 pandemic is in a massive second wave in India. The new variant is considered more infectious. Diabetic patients are considered more vulnerable to develop some of the complications of acute Covid-19 infections. Furthermore, steroids are being used in the treatment of Covid-19 related pneumonia in a large number of patients. Hence, secondary fungal infections are being increasing observed, with very high mortality. We present the clinical, imaging and histopathological features in a diabetic patient who recovered from acute Covid-19 infection. However, he developed palatal and maxillary mucormycosis. Mucosal debridement, sinus surgery and antifungal treatment led to a satisfactory outcome.

A 42-years old diabetic man developed fever, running nose, dry cough with generalized malaise 5-weeks ago. Reverse transcriptase polymerase chain reaction test for coronavirus disease (Covid-19) was positive (cycle threshold value 19). Since his cough increased and hypoxia (lowest pulse oxygenation 86%) were observed during the second week, computerized tomography of the chest was performed that showed patches of consolidation (CT score 16). He was treated with intravenous Remdesivir and dexamethasone for 6-days. His glycated hemoglobin (HbA1c) was 8.1%, therefore blood sugar levels were controlled with subcutaneous insulin during the hospital stay. He recovered satisfactorily and was discharged on oral glipizide, metformin and dexamethasone.

One week later, he was readmitted due to generalised headache, toothache, blocked nose and intermittent blackish discharge from left nostril. Clinical examination revealed tenderness over both maxillary sinuses and an ulcerative eschar at the hard palate ( Figure 1A ). Magnetic resonance imaging of paranasal sinuses showed altered signals in both maxillary sinuses, left agar nasi, rarefaction of left middle turbinate and uncinate process, thinning of posterolateral wall of left maxillary sinus and mild oedema of left hard palate and alveolar arch ( Figure 1B ). Serum ferritin level was 598ng/ml (normal range 20-250ng/ml). Nasal endoscopy was performed and the aspirate was examined (D).

Nasal aspirate was stained with potassium hydroxide, which revealed pauciseptate fungal hyphae, suggestive of mucormycosis. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 He underwent bilateral modified Denker's procedure and removal of the palatal submucosal layer. Intravenous liposomal amphotericin B (10mg/Kg/body-weight) and ceftriaxone (2Gm/day), along with optimal control of diabetes resulted in satisfactory recovery during next 3-weeks.

Mucormycosis is rare opportunistic fungal infection characterized by infarction and necrosis of host tissues that results from angio-invasion by hyphae. 1 The infection usually starts in paranasal sinuses and rapidly extends into the palate and orbit.

immunocompromised state often causes significant morbidity and mortality. 2, 3 Optimal control of diabetes, judicious use of corticosteroids, early diagnosis and treatment are important for improving outcomes of this dreaded post-Covid complication with high mortality. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Legend to the figure 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 

Disease entities in mucormycosis

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Challenges in the diagnosis and treatment of mucormycosis

Manuscripts submitted to QJM